tiprankstipranks
Trending News
More News >
Aptose Biosciences Reports Promising AML Trial Results and Expands Market Presence
PremiumCompany AnnouncementsAptose Biosciences Reports Promising AML Trial Results and Expands Market Presence
1M ago
Aptose Biosciences Reports Promising Results from TUSCANY Trial for AML Treatment
Premium
Company Announcements
Aptose Biosciences Reports Promising Results from TUSCANY Trial for AML Treatment
1M ago
Aptose Biosciences Auditor KPMG Not Re-Appointed
Premium
Company Announcements
Aptose Biosciences Auditor KPMG Not Re-Appointed
2M ago
Aptose Biosciences price target raised to $6 from $2 at H.C. Wainwright
PremiumThe FlyAptose Biosciences price target raised to $6 from $2 at H.C. Wainwright
3M ago
Aptose Biosciences Advances AML Therapy and Strengthens Financial Position
Premium
Company Announcements
Aptose Biosciences Advances AML Therapy and Strengthens Financial Position
3M ago
Aptose Biosciences reports FY24 EPS ($36.38) vs. ($227.43) last year
Premium
The Fly
Aptose Biosciences reports FY24 EPS ($36.38) vs. ($227.43) last year
3M ago
Aptose Biosciences trading halted, news pending
PremiumThe FlyAptose Biosciences trading halted, news pending
4M ago
Aptose Biosciences Advances TUSCANY Trial Dosage Escalation
Premium
Company Announcements
Aptose Biosciences Advances TUSCANY Trial Dosage Escalation
4M ago
Aptose Biosciences approved to escalate dose in Phase 1/2 AML trial
Premium
The Fly
Aptose Biosciences approved to escalate dose in Phase 1/2 AML trial
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100